Literature DB >> 10567296

Repair of tetralogy of Fallot in neonates and young infants.

F A Pigula1, P N Khalil, J E Mayer, P J del Nido, R A Jonas.   

Abstract

BACKGROUND: The timing of repair of tetralogy of Fallot (TOF) remains controversial. Advantages to early complete repair include removal of right ventricular outflow tract obstruction, alleviation of systemic hypoxia, and avoidance of palliation with an arteriopulmonary shunt. METHODS AND
RESULTS: This is a retrospective review of 99 children with TOF pulmonary stenosis (TOF/PS) or TOF pulmonary atresia (TOF/PA) who were <90 days of age undergoing early complete repair. Fifty-nine were prostaglandin E dependent, and 91% of neonates were symptomatic at the time of repair. Univariate and multivariate analyses of patient characteristics, anatomic features, and operative management showed the diagnosis of TOF/PA and smaller body surface area to be the only independent risk factors for death. Early mortality was 3% (3 of 99), and actuarial survival rates were 94% at 1 year and 91.6% at 5 years. Freedom from catheterization was 86% at 1 year and 73% at 5 years. Patients repaired for TOF/PA had a significantly lower freedom from reoperation than did those repaired for TOF/PS.
CONCLUSIONS: Early complete TOF repair can be accomplished with a low mortality. Children with TOF/PA repaired had a lower freedom from reoperation that did those with TOF/PS. Longer follow-up, with emphasis on arrhythmias and right ventricular function, is required to define the long-term benefits of early repair.

Entities:  

Mesh:

Year:  1999        PMID: 10567296     DOI: 10.1161/01.cir.100.suppl_2.ii-157

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  46 in total

1.  The unnatural history of tetralogy of Fallot: surgical repair is not as definitive as previously thought.

Authors:  C van Doorn
Journal:  Heart       Date:  2002-11       Impact factor: 5.994

2.  [Cardiology on the edge of the right track].

Authors:  Bernhard Maisch; Helmut Drexler
Journal:  Herz       Date:  2009-03       Impact factor: 1.443

Review 3.  Molecular and cellular mechanisms of T cell development.

Authors:  U Bommhardt; M Beyer; T Hünig; H M Reichardt
Journal:  Cell Mol Life Sci       Date:  2004-02       Impact factor: 9.261

4.  Repaired tetralogy of Fallot with coexisting unrepaired partial anomalous pulmonary venous connection is associated with diminished right ventricular ejection fraction and more severe right ventricular dilation.

Authors:  Sherwin S Chan; Kevin K Whitehead; Timothy S Kim; Gregory L Fu; Marc S Keller; Mark A Fogel; Matthew A Harris
Journal:  Pediatr Radiol       Date:  2015-05-03

5.  Perioperative care of children with tetralogy of fallot.

Authors:  Satish K Rajagopal; Ravi R Thiagarajan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-10

6.  Heart rate variability and exercise capacity of patients with repaired tetralogy of Fallot.

Authors:  Suchaya Silvilairat; Jatuporn Wongsathikun; Rekwan Sittiwangkul; Yupada Pongprot; Nipon Chattipakorn
Journal:  Pediatr Cardiol       Date:  2011-07-08       Impact factor: 1.655

Review 7.  Intestinal microbiota and blue baby syndrome: probiotic therapy for term neonates with cyanotic congenital heart disease.

Authors:  Collin L Ellis; John C Rutledge; Mark A Underwood
Journal:  Gut Microbes       Date:  2010 Nov-Dec

8.  Stenting of the right ventricular outflow tract in the high-risk infant with cyanotic teratology of Fallot.

Authors:  Chesney D Castleberry; Todd M Gudausky; Stuart Berger; James S Tweddell; Andrew N Pelech
Journal:  Pediatr Cardiol       Date:  2013-10-06       Impact factor: 1.655

9.  Tetralogy of Fallot: Current surgical perspective.

Authors:  Tom R Karl
Journal:  Ann Pediatr Cardiol       Date:  2008-07

10.  Balloon pulmonary valvotomy as interim palliation for symptomatic young infants with tetralogy of Fallot.

Authors:  K S Remadevi; Balu Vaidyanathan; Edwin Francis; B R J Kannan; Raman Krishna Kumar
Journal:  Ann Pediatr Cardiol       Date:  2008-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.